NASDAQ: BIOXBioceres Crop Solutions Corp Stock
$0.33-0.03 (-8.33%)
Updated Jul 7, 2026
BIOX Price
$0.33
Fair Value Price
N/A
Market Cap
$20.92M
52 Week Low
$0.31
52 Week High
$4.57
P/E
N/A
P/B
0.33x
P/S
0.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$264.14M
Earnings
-$72.66M
Gross Margin
37.7%
Operating Margin
-0.8%
Profit Margin
-27.5%
Debt to Equity
6.89
Operating Cash Flow
N/A
Beta
0.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BIOX Overview
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BIOX's potential to beat the market
- BIOX doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Agricultural Input
Industry Rating
B
BIOX
RankedUnranked of 11
RankedUnranked of 11
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $114.93 | B | |
| $66.79 | B | |
| $4.95 | B |
Be the first to know about important BIOX news, forecast changes, insider trades & much more!
BIOX News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BIOX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BIOX is good value based on its book value relative to its share price (0.33x), compared to the US Agricultural Inputs industry average (1.69x)
P/B vs Industry Valuation
BIOX's profit margin has decreased (-28%) in the last year from (0.5%) to (-27.5%)
Profit Margin Growth Financials
BIOX's short-term liabilities ($308.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more BIOX due diligence checks available for Premium users.
Valuation
BIOX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
38.24x
Market
8.58x
BIOX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.33x
Industry
1.69x
BIOX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BIOX's financial health
Profit margin
Revenue
$39.4M
Net Income
-$12.4M
Profit Margin
-31.5%
BIOX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$531.4M
Liabilities
$439.7M
Debt to equity
6.89
BIOX's short-term liabilities ($308.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BIOX's short-term assets ($261.20M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BIOX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BIOX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
BIOX vs Agricultural Input Stocks
Bioceres Crop Solutions Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.